Sichuan Kelun Pharmaceutical Co., Ltd. (SHE: 002422)

Sichuan Kelun Pharmaceutical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	5,128	4,675	4,729	2,920	2,772	2,253
Short-Term Investments	-	579.39	-	-	-	-
Trading Asset Securities	1,956	1,691	448.11	359.53	265.42	-
Cash & Short-Term Investments	7,084	6,946	5,177	3,279	3,037	2,253
Cash Growth	2.03%	34.17%	57.88%	7.96%	34.79%	11.23%
Accounts Receivable	6,403	6,120	7,198	6,463	7,432	7,495
Other Receivables	185.4	162.49	256.3	221.92	117.57	352.87
Receivables	6,589	6,283	7,454	6,685	7,549	7,848
Inventory	3,293	3,840	3,214	3,363	3,468	3,386
Other Current Assets	2,100	1,222	804.22	681.4	645.3	687.01
Total Current Assets	19,066	18,290	16,649	14,009	14,700	14,174
Property, Plant & Equipment	12,998	12,086	11,331	11,614	11,987	12,122
Long-Term Investments	4,180	3,992	3,809	3,409	2,751	2,762
Goodwill	98.66	98.66	98.66	98.66	158.45	158.45
Other Intangible Assets	1,220	1,277	1,201	1,063	987.8	941.87
Long-Term Deferred Tax Assets	390.64	342.57	618.21	581.57	552.18	464.11
Long-Term Deferred Charges	90.45	75.72	233.81	365.28	516.12	556.22
Other Long-Term Assets	348.05	293.17	264.34	400.05	330.62	305.82
Total Assets	38,392	36,455	34,206	31,540	31,983	31,485
Accounts Payable	2,437	2,539	2,244	2,156	1,861	876.74
Accrued Expenses	444.55	2,028	1,973	1,610	2,525	3,298
Short-Term Debt	3,519	3,458	4,499	5,183	5,067	4,387
Current Portion of Long-Term Debt	748.86	746.86	2,012	3,199	2,208	5,084
Current Portion of Leases	-	40.53	17.31	11.57	-	-
Current Income Taxes Payable	284.07	162.74	108.18	119.48	92.6	107.39
Current Unearned Revenue	237.14	715.24	360.36	264.69	187.88	168.98
Other Current Liabilities	2,472	302.46	889.3	864.55	316.52	897.74
Total Current Liabilities	10,143	9,993	12,104	13,408	12,258	14,820
Long-Term Debt	888.95	2,649	4,704	3,506	5,100	2,147
Long-Term Leases	558.84	245.23	51.74	16.18	-	-
Long-Term Unearned Revenue	292.04	288.21	208.88	225.73	362.07	364.42
Long-Term Deferred Tax Liabilities	272.9	264.1	265.83	254.32	260.55	247.98
Other Long-Term Liabilities	5.47	0.08	-	-	-	-
Total Liabilities	12,161	13,439	17,335	17,410	17,980	17,579
Common Stock	1,602	1,499	1,422	1,425	1,439	1,440
Additional Paid-In Capital	8,301	6,144	3,673	3,581	3,889	3,549
Retained Earnings	12,757	11,973	10,416	9,328	8,675	8,448
Treasury Stock	-192.98	-215.14	-237.08	-399.98	-499.88	-380.3
Comprehensive Income & Other	87.66	272.07	459.82	-77.49	-3.51	131.11
Total Common Equity	22,555	19,672	15,734	13,857	13,499	13,188
Minority Interest	3,676	3,343	1,137	272.62	503.99	717.99
Shareholders' Equity	26,231	23,016	16,871	14,129	14,003	13,906
Total Liabilities & Equity	38,392	36,455	34,206	31,540	31,983	31,485
Total Debt	5,715	7,139	11,285	11,916	12,375	11,618
Net Cash (Debt)	1,369	-193.52	-6,108	-8,637	-9,337	-9,364
Net Cash Per Share	0.87	-0.13	-4.12	-6.11	-6.53	-6.55
Filing Date Shares Outstanding	1,586	1,488	1,412	1,406	1,430	1,440
Total Common Shares Outstanding	1,586	1,488	1,412	1,406	1,430	1,440
Working Capital	8,923	8,297	4,545	600.44	2,442	-645.94
Book Value Per Share	14.22	13.22	11.15	9.85	9.44	9.16
Tangible Book Value	21,236	18,297	14,434	12,695	12,353	12,088
Tangible Book Value Per Share	13.39	12.29	10.23	9.03	8.64	8.40
Buildings	-	6,557	6,160	6,057	5,932	5,833
Machinery	-	11,592	11,348	11,078	10,793	10,098
Construction In Progress	-	2,045	1,126	922.73	840.67	782.4

Source: S&P Capital IQ. Standard template. Financial Sources.